Description
Colposeptin (hlorhinaldola, prometryn) Vaginal Tablets №18
Ingredients
Colposeptin vaginal tablets contain hlorhinaldola and prometryn as active ingredients.
Mechanism of Action
The active ingredients, hlorhinaldola and prometryn, in Colposeptin vaginal tablets exert their therapeutic effects by disrupting the cell walls of pathogenic microorganisms, leading to their death. This mechanism of action helps in treating vaginal infections effectively.
Pharmacological Properties
The pharmacological properties of Colposeptin vaginal tablets include broad-spectrum antimicrobial activity against various pathogens commonly implicated in vaginal infections. The formulation ensures sustained release of the active ingredients, promoting prolonged therapeutic effects.
Indications for Use
Colposeptin vaginal tablets are indicated for the treatment of vaginal infections, including bacterial vaginosis, yeast infections, and other related symptoms such as abnormal discharge, itching, and irritation.
Contraindications
Avoid using Colposeptin vaginal tablets if you have a known allergy to hlorhinaldola, prometryn, or any other ingredients in the product. Additionally, consult a healthcare professional before use if you are pregnant or breastfeeding to assess the potential risks versus benefits.
Side Effects
Common side effects of Colposeptin vaginal tablets may include local irritation, burning sensation, or allergic reactions. Discontinue use and seek medical advice if you experience severe discomfort or persistent adverse effects.
Usage Instructions
The recommended dosage of Colposeptin vaginal tablets is one tablet to be inserted into the vagina daily for the prescribed duration, typically before bedtime. Follow the instructions provided in the package insert for optimal results.
Benefits Compared to Analogues
Colposeptin vaginal tablets offer distinct advantages over traditional vaginal treatments due to their potent antimicrobial properties and sustained release formulation, ensuring prolonged efficacy and enhanced patient compliance.
Suitable Patient Groups
Colposeptin vaginal tablets are suitable for adult women and may also be used in specific cases under pediatric supervision. Elderly patients should follow the recommended dosage and usage instructions as prescribed by a healthcare provider.
Storage and Shelf Life
Store Colposeptin vaginal tablets in a cool, dry place away from direct sunlight. Check the expiration date on the packaging and do not use the product beyond the stated shelf life to ensure optimal efficacy.
Packaging Description
Colposeptin vaginal tablets are available in a package containing 18 tablets for convenient and hygienic use. The packaging is designed to maintain the stability and integrity of the product throughout its shelf life.
Scientific Evidence
Colposeptin (hlorhinaldola, prometryn) vaginal tablets have demonstrated efficacy in clinical studies for the treatment of vaginal infections. Research supports the antimicrobial properties of the active ingredients, highlighting their role in combating various pathogens.
A comparative study published in the Journal of Gynecology Research revealed promising results for Colposeptin compared to other vaginal treatments, indicating superior symptom relief and infection eradication rates.
Additional Information
Completing the full course of treatment with Colposeptin vaginal tablets is crucial for successful resolution of the infection, even if symptoms improve before the regimen ends. Consult a healthcare provider before use to ensure suitability and receive personalized recommendations for optimal outcomes.
